HCA
ISEE

Hillview Capital Advisors’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

Hillview Capital Advisors’s Portfolio ISEE Stock Details ISEE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-12,330
Closed -$642K – 20
2015
Q2 		$642K Sell
12,330
-22,500
-65% -$1.12M 0.63% 5
2015
Q1 		$1.62M Sell
34,830
-45,000
-56% -$2.34M 1.4% 5
2014
Q4 		$3.58M Buy
+79,830
New +$3.35M 3.11% 3

Other funds holding ISEE

NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JCG
JHL Capital Group Chicago, Illinois $805M AUM 50.84% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SHI
SV Health Investors Boston, Massachusetts $32.3M AUM 20.15% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Hillview Capital Advisors's ISEE Position: Q3 2015 in Review

Hillview Capital Advisors sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q3 2015, closing a stake of 12,330 shares — an estimated $642K sold.

Hillview Capital Advisors first reported a position in ISEE in Q4 2014 and held it in 3 quarters. The position peaked at $3.58M in Q4 2014. 144 funds tracked by Wall St. Rank hold ISEE as of Q3 2015.

  • Hillview Capital Advisors reported no remaining IVERIC bio, Inc. Common Stock position as of Q3 2015 after selling out during the quarter.
  • Hillview Capital Advisors sold 12,330 IVERIC bio, Inc. Common Stock shares in Q3 2015, an estimated $642K.
  • Hillview Capital Advisors first reported a position in IVERIC bio, Inc. Common Stock in Q4 2014 and held it in 3 quarters.
  • Hillview Capital Advisors's IVERIC bio, Inc. Common Stock position peaked at $3.58M in Q4 2014.
  • 144 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q3 2015.

Based on Hillview Capital Advisors's 13F filing for Q3 2015, filed 16 Nov 2015.